Product Name: Ethyl 7-Chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (Ozenoxacin Intermediate A)
CAS No.: 103877-51-6
Molecular Formula: C₁₅H₁₅ClNO₃
Molecular Weight: 292.74
🌟 Product Overview
Brief Introduction: A critical intermediate in the synthesis of Ozenoxacin, a non-fluorinated quinolone antibacterial agent used to treat superficial skin infections like impetigo. This high-purity compound ensures efficient production of the final API (Active Pharmaceutical Ingredient).
Primary Function: Key building block for Ozenoxacin synthesis, enabling precise structural modification in pharmaceutical manufacturing.
Applicable Fields: Antibacterial drug development, API production, and fine chemical research.
✅ Key Advantages
🟡 ≥99% Purity: Verified by HPLC and NMR, ensuring compliance with pharmaceutical-grade standards.
🟡 Bulk Availability: Offered in flexible quantities (1g to 25kg) with rapid delivery options.
🟡 Stability: Long-term storage stability under controlled conditions (room temperature, dry environment).
📌 Application Scenarios
Ozenoxacin Synthesis: Essential for manufacturing the non-fluorinated quinolone antibacterial agent.
API Development: Used in preclinical and commercial stages for antibacterial drug formulations.
Research Use: Supports studies on quinolone derivatives and antimicrobial resistance mechanisms.
🔬 Quality Certifications
Testing Standards: Complies with USP/EP guidelines; validated by HPLC (>99%), NMR, and mass spectrometry.
Documentation: COA, HPLC, and NMR reports provided for regulatory compliance.
📈 Market Trends
Demand for this intermediate is rising due to the expanding use of Ozenoxacin in treating antibiotic-resistant skin infections, particularly in pediatric populations. The Asia-Pacific region dominates production, driven by pharmaceutical companies scaling API manufacturing post-patent expiration.
China
